Jared is a freelance writer for The American Journal of Managed Care® (AJMC®), and previously worked as a senior editor for HCPLive® at MJH Life Sciences®.
He has an MA from University of Sioux Falls. You can connect with Jared on LinkedIn.
Exploring Biomarker-Based Risk Stratification in Smoldering Multiple Myeloma
December 9th 2020The science around risk stratification in patients with smoldering multiple myeloma (SMM) has been evolving over the past 2 decades. A new study validates some, though not all, of the proposed biomarkers.
Read More
African American Men Face Higher Risk of Aggressive Prostate Cancer, but Not Necessarily Death
November 26th 2020Multiple studies have suggested African American men tend to have more aggressive forms of prostate cancer, but a new study suggests that may not translate to a higher risk of death.
Read More
Late Effects of Therapy Plague Many Patients Who Survived AML as Youths, Young Adults
November 23rd 2020Most patients who are diagnosed with acute myeloid leukemia are in middle or old age. The relatively small number who are diagnosed earlier in life can be subject to long-term health risks due to their treatment.
Read More
Male, White, Older Patients With Leukemia at Heightened Risk of Suicide, Study Finds
November 11th 2020In what is believed to be the first study of its kind, investigators found patients with leukemia face a higher risk of suicide than the general public, especially if they had acute myeloid leukemia.
Read More
Patients With ALL Have High Readmission Risk Post Chemotherapy, but Hospitals Can Change That
November 5th 2020Many patients with acute lymphoblastic leukemia (ALL) who undergo chemotherapy end up back in the hospital within 30 days. A new study points out the reasons and opportunities for prevention.
Read More
Use of Triplet Therapy Rose in R/R MM as Deaths Declined, Study Finds
October 29th 2020Newer therapies have led to a boost in the number of patients with relapsed or refractory multiple myeloma (R/R MM) who are prescribed triplet regimens. As that shift has occurred, death rates appear to have dropped.
Read More
Prior Malignancy Linked to Risk of Secondary Malignancy in Follicular Lymphoma
October 29th 2020Previous research has found a link between a prior malignancy and secondary primary malignancy risk in patients with multiple myeloma. A new study suggests a similar association in follicular lymphoma.
Read More